Cargando…
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
Both KRAS and EGFR are essential mediators of pancreatic cancer development and interact with Argonaute 2 (AGO2) to perturb its function. Here, in a mouse model of mutant KRAS-driven pancreatic cancer, loss of AGO2 allows precursor lesion (PanIN) formation yet prevents progression to pancreatic duct...
Autores principales: | Shankar, Sunita, Tien, Jean Ching-Yi, Siebenaler, Ronald F., Chugh, Seema, Dommeti, Vijaya L., Zelenka-Wang, Sylvia, Wang, Xiao-Ming, Apel, Ingrid J., Waninger, Jessica, Eyunni, Sanjana, Xu, Alice, Mody, Malay, Goodrum, Andrew, Zhang, Yuping, Tesmer, John J., Mannan, Rahul, Cao, Xuhong, Vats, Pankaj, Pitchiaya, Sethuramasundaram, Ellison, Stephanie J., Shi, Jiaqi, Kumar-Sinha, Chandan, Crawford, Howard C., Chinnaiyan, Arul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272436/ https://www.ncbi.nlm.nih.gov/pubmed/32499547 http://dx.doi.org/10.1038/s41467-020-16309-2 |
Ejemplares similares
-
Argonaute 2 modulates EGFR–RAS signaling to promote mutant HRAS and NRAS-driven malignancies
por: Siebenaler, Ronald F, et al.
Publicado: (2022) -
Biochemical characterization of the interaction between KRAS and Argonaute 2
por: Waninger, Jessica J., et al.
Publicado: (2021) -
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
por: Zhang, Yuping, et al.
Publicado: (2021) -
AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer
por: Tien, Jean Ching-Yi, et al.
Publicado: (2021) -
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)